Phesgo SC (perjeta and herceptin)

pCPA File Number: 21762

Negotiation Status:

Concluded without agreement

Indication(s):

For the first-line treatment of patients with HER2-positive metastatic breast cancer

Sponsor/Manufacturer:

HOFFMANN-LA ROCHE LIMITED

CADTH Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2022-02-28

Negotiation Process Concluded:

2022-05-19